bioRxivMicrobiologyPreprint
Phage-Nanoparticle Cocktails as a Novel Antibacterial Approach: Synergistic Effects of Bacteriophages and Green-Synthesized Silver Nanoparticles
Mateusz WdowiakiD, Sada RazaiD, Mateusz Grotek, Rafał ZbonikowskiiD, Julita NowakowskaiD, Maria DoligalskaiD, Ningjing Cai, Zhi LuoiD, Jan PaczesnyiD
Abstract
Bacteriophages have emerged as promising natural antibacterial agents, offering a targeted approach to combating bacterial infections. While phage-antibiotic cocktails are widely explored to enhance antibacterial efficacy and prevent resistance, research on phage-nanoparticle combinations remains limited. However, antibiotic resistance continues to rise, necessitating alternative strategies. Combining bacteriophages with nanoparticles presents a novel approach that could enhance antibacterial potency while reducing the risk of resistance, yet studies in this area are still scarce. We explore the synergy between green tea extract-capped silver nanoparticles (G-TeaNPs) and bacteriophages in combating pathogenic bacteria (Staphylococcus aureus, Salmonella enterica). G-TeaNPs show no antiphage activity, ensuring compatibility in phage-NP formulations. These combinations significantly reduce bacterial counts in a short time (only 3 hours), e.g., S. aureus survival is around 30% after incubations with just 0.001 mg/mL of G-TeaNPs, with G-TeaNPs and phages alone result in around 80% and 70% survival, respectively. Cytotoxicity tests against eukaryotic 3T3 NIH fibroblast cells confirmed biocompatibility at effective concentrations. Additionally, we examine G-TeaNPs impact on the free-living protist Acanthamoeba castellanii. Both green tea extract and G-TeaNPs can reduce A. castellanii cell counts by 80%, but only at concentrations larger than 10 mg/mL. Microscopy revealed nanoparticle uptake by amoebae, causing intracellular accumulation and vacuolization, while green tea extract induced similar changes without uptake. Our findings highlight G-TeaNPs as safe, effective agents in phage-nanoparticle antibacterial formulations with dual antimicrobial and amoebicidal properties for therapeutic and environmental applications.
- organism: human
- organism: mouse
- organism: rat
- assay: proteomics
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Treatment of wound infections in a mouse model using Zn2+-releasing phage bound to gold nanorods
H. PENG, D. Rossetto, … I. Chen·bioRxiv·Jan 5, 2022
- A Blueprint for Broadly Effective Bacteriophage Therapy Against Bacterial Infections
Minyoung Kevin Kim, Qingquan Chen, … Paul L. Bollyky·Nature CommunicationsPeer-reviewed·Nov 28, 2024
- Antagonism between bacteriophages and macrophages decreases efficacy of a phage cocktail and increases bacteriophage resistance
Meaghan Castledine, Zuzanna Szczutkowska, … Angus G. J. Buckling·bioRxiv·May 16, 2025
- Antibacterial activity against Escherichia coli: A proof-of-concept study of colloidally aggregated silver nanoparticles with experimental evidence
Mateen Ur Rehman, Sobia Saeed·bioRxiv·Apr 13, 2026
- Pulsed blue light and phage therapy: A novel synergistic bactericide
Amit Rimon, Jonathan Belin, … Lilach Gavish·AntibioticsPeer-reviewed·May 9, 2025
- Characterization of phage-antibiotic interaction through different in vitro methods: case study of a vibriophage
Brunel Archambeaud, Clément Douarre, Pierre R. Marcoux·bioRxiv·May 27, 2026